Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;99(2):777-786.
doi: 10.1111/php.13738. Epub 2022 Dec 1.

A Lock-and-Kill Anticancer Photoactivated Chemotherapy Agent†

Erik Pieter van Geest  1 , Sina Katharina Götzfried  1 , David M Klein  1 , Nadiya Salitra  1 , Sorraya Popal  1 , Yurii Husiev  1 , Corjan J Van der Griend  1 , Xuequan Zhou  1 , Maxime A Siegler  2 , Gregory F Schneider  1 , Sylvestre Bonnet  1
Affiliations

A Lock-and-Kill Anticancer Photoactivated Chemotherapy Agent†

Erik Pieter van Geest et al. Photochem Photobiol. 2023 Mar.

Abstract

Photosubstitutionally active ruthenium complexes show high potential as prodrugs for the photoactivated chemotherapy (PACT) treatment of tumors. One of the problems in PACT is that the localization of the ruthenium compound is hard to trace. Here, a ruthenium PACT prodrug, [Ru(3)(biq)(STF-31)](PF6 )2 (where 3 = 3-(([2,2':6',2″-ter- pyridin]-4'-yloxy)propyl-4-(pyren-1-yl)butanoate) and biq = 2,2'-biquinoline), has been prepared, in which a pyrene tracker is attached via an ester bond. The proximity between the fluorophore and the ruthenium center leads to fluorescence quenching. Upon intracellular hydrolysis of the ester linkage, however, the fluorescence of the pyrene moiety is recovered, thus demonstrating prodrug cellular uptake. Further light irradiation of this molecule liberates by photosubstitution STF-31, a known cytotoxic nicotinamide phosphoribosyltransferase (NAMPT) inhibitor, as well as singlet oxygen via excitation of the free pyrene chromophore. The dark and light cytotoxicity of the prodrug, embedded in liposomes, as well as the appearance of blue emission upon uptake, were evaluated in A375 human skin melanoma cells. The cytotoxicity of the liposome-embedded prodrug was indeed increased by light irradiation. This work realizes an in vitro proof-of-concept of the lock-and-kill principle, which may ultimately be used to design strategies aimed at knowing where and when light irradiation should be realized in vivo.

PubMed Disclaimer

References

REFERENCES

    1. Mjos, K. D. and C. Orvig (2014) Metallodrugs in medicinal inorganic chemistry. Chem. Rev. 114, 4540-4563.
    1. Clarke, M. J. (2002) Ruthenium metallopharmaceuticals. Coord. Chem. Rev. 232, 69-93.
    1. Morris, R. E., R. E. Aird, P. D. Murdoch, H. M. Chen, J. Cummings, N. D. Hughes, S. Parsons, A. Parkin, G. Boyd, D. I. Jodrell and P. J. Sadler (2001) Inhibition of cancer cell growth by ruthenium(II) arene complexes. J. Med. Chem. 44, 3616-3621.
    1. Sava, G., S. Zorzet, C. Turrin, F. Vita, M. Soranzo, G. Zabucchi, M. Cocchietto, A. Bergamo, S. DiGiovine, G. Pezzoni, L. Sartor and S. Garbisa (2003) Dual action of NAMI-A in inhibition of solid tumor metastasis: Selective targeting of metastatic cells and binding to collagen. Clin. Cancer Res. 9, 1898-1905.
    1. Monro, S., K. L. Colón, H. Yin, J. Roque, P. Konda, S. Gujar, R. P. Thummel, L. Lilge, C. G. Cameron and S. A. McFarland (2019) Transition metal complexes and photodynamic therapy from a tumor-centered approach: Challenges, opportunities, and highlights from the development of TLD1433. Chem. Rev. 119, 797-828.

Publication types

LinkOut - more resources